je.st
news
Tag: application
Fiserv Earns SWIFT Certified Application for Reconciliation Accreditation for the 14th ...
2013-09-12 06:00:00| Industrial Newsroom - All News for Today
Brookfield, Wis.– Sibos Stand D27 – Fiserv, Inc. (NASDAQ: FISV), a leading global provider of financial services technology solutions, today announced that its Accurate™ Reconciliation solution for transaction matching, reconciliation and exception management has received the 2013 SWIFT Certified Application for Reconciliation label.<br /> <br /> "Fiserv has once again met the stringent criteria set out by SWIFT," said Filip Versluys, Head of Partner Management at SWIFT. "The ...This story is related to the following:Accounting & Financial Software |
Tags: the
application
certified
14th
Eagle Launches Asset Management Application on Johnson Controls' Panoptix® App ...
2013-09-10 06:00:00| Industrial Newsroom - All News for Today
Eagle’s Intelligent Facility Software Provides Cost Savings to Building Owners<br /> <br /> MILWAUKEE – Eagle Technology, Inc. has launched its Proteus MMX Asset Manager for Intelligent Facilities solution to help reduce costs of operation through improved asset scheduling and tracking. The Proteus MMX Asset Manager application will be included at no cost on the Johnson Controls Panoptix application marketplace.<br /> <br /> The Eagle Technology software provides actionable data ...This story is related to the following:Asset Management Software
Tags: management
application
johnson
controls
Jr. GRUNT application and permission slip
2013-09-09 22:39:35| PortlandOnline
PDF Document, 509kbCategory: Teen Nature Program
Tags: application
permission
slip
grunt
Merck Announces FDA Acceptance of New Drug Application for Investigational Fertility Treatment
2013-09-09 14:30:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the New Drug Application (NDA) for its investigational fertility treatment, corifollitropin alfa, has been accepted for standard review by the U.S. Food and Drug Administration (FDA). Merck is seeking FDA approval of corifollitropin alfa for Controlled Ovarian Stimulation (COS) in women participating in assisted reproductive technology. Language: English Contact: MerckMedia:Pam Eisele, 908-423-5042orTina Grasso, 267-893-9783orInvestors:Carol Ferguson, 908-423-4465 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: application
treatment
drug
acceptance
Utility License Application
2013-09-06 16:36:24| PortlandOnline
All lines must be completed for an application to be processed
Tags: application
license
utility
license application
Sites : [347] [348] [349] [350] [351] [352] [353] [354] [355] [356] [357] [358] [359] [360] [361] [362] [363] [364] [365] [366] next »